# Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

> **NCT05208190** · PHASE4 · RECRUITING · sponsor: **New York State Psychiatric Institute** · enrollment: 280 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Clozapine
- **DRUG:** treatment as usual

## Key facts

- **NCT ID:** NCT05208190
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-17
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05208190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05208190, "Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05208190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*